Nexien BioPharma(NXEN)
$0.000.00 (0.00%)
NXEN
Nexien BioPharma financials statements
$0.00
At close:0.00 (0.00%)
Nexien BioPharma (NXEN) Income Statement
6 Followers
Nexien BioPharma Income Statement
Last quarter (Q3 2025), Nexien BioPharma's total revenue was $0.00. In Q3, Nexien BioPharma's net income was $-30.09K. See Nexien BioPharma’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Jun 24 | Jun 23 | Jun 22 | Jun 21 | Jun 20 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 155.66K | $ 282.61K | $ 340.74K | $ 1.84M | $ 2.64M | |
| Depreciation and Amortization | $ 155.66K | $ 49.76K | $ 563.99K | $ 1.84M | $ 2.64M |
| $ -337.00 | $ -233.24K | $ -8.00 | $ -233.00 | $ -35.42K | |
| $ -156.00K | $ -283.00K | $ -340.74K | $ -750.10K | $ -2.64M | |
| $ -83.45K | $ -79.29K | $ -285.62K | $ -1.11M | $ -35.03K | |
| $ -239.00K | $ -362.00K | $ -626.00K | $ -1.86M | $ -2.67M | |
| $ -239.00K | $ -362.00K | $ -626.00K | $ -1.86M | $ -2.67M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.00 | $ -0.01 | $ -0.01 | $ -0.03 | $ -0.05 |
| Diluted EPS | $ -0.00 | $ -0.01 | $ -0.01 | $ -0.03 | $ -0.05 |
| Weighted Average Shares Outstanding | 66.19M | 62.33M | 57.86M | 55.40M | 53.91M |
| Weighted Average Shares Outstanding (Diluted) | 66.19M | 62.33M | 57.86M | 55.40M | 53.91M |
Currency in USD

